molybdenum has been researched along with Head and Neck Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, J; Liu, M; Liu, T; Tu, Z; Wen, W; Xie, X; Zhang, S; Zhu, Y | 1 |
| Akiyama, K; Hasegawa, K; Ibaragi, S; Kishimoto, K; Kunisada, Y; Monsur Hassan, NM; Okui, T; Ryumon, S; Sasaki, A; Shimo, T; Thu Ha, NT | 1 |
| Hassan, NMM; Ibaragi, S; Morisawa, A; Nguyen, TTH; Okui, T; Okusha, Y; Ono, M; Sasaki, A; Shimo, T | 1 |
| Islam, M; Kumar, P; Merajver, SD; Pan, Q; Patel, SN; Teknos, TN; Yadav, A | 1 |
| Abarbanell, AM; Arenberg, DA; Carron, M; Carskadon, SL; Islam, M; Marcus, B; Merajver, SD; Nor, JE; Pan, Q; Paul, S; Teknos, TN; Vandenberg, CD | 1 |
| Bolton, B; Brewer, G; Kariapper, MS; Khan, MK; Kwitny, A; Mamou, F; May, KS; Merajver, SD; Miller, M; Nair, BM; Normolle, D; Schipper, MJ; Teknos, TN; Warnat, A | 1 |
| Hassouneh, B; Islam, M; Merajver, SD; Nagel, T; Pan, Q; Teknos, TN | 1 |
| Khan, GN; Merajver, SD | 1 |
| Barrios, M; Brewer, GJ; Cox, C; Dick, RD; Merajver, SD; Teknos, TN | 1 |
1 review(s) available for molybdenum and Head and Neck Neoplasms
| Article | Year |
|---|---|
Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Carotenoids; Cell Transformation, Neoplastic; Chelating Agents; Copper; Dietary Supplements; Female; Flavonoids; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molybdenum; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenols; Polyphenols; Prostatic Neoplasms; Reactive Oxygen Species | 2007 |
8 other study(ies) available for molybdenum and Head and Neck Neoplasms
| Article | Year |
|---|---|
Construction of CpG Delivery Nanoplatforms by Functionalized MoS
Topics: Cytokines; Head and Neck Neoplasms; Humans; Immunotherapy; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2023 |
Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Drug Synergism; Head and Neck Neoplasms; Humans; Male; Mice; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tissue Array Analysis; Xenograft Model Antitumor Assays | 2019 |
Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
Topics: Animals; Antineoplastic Agents, Immunological; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Cetuximab; Chelating Agents; Copper; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molybdenum; Neoplasm Invasiveness; Osteoclasts; Protein-Lysine 6-Oxidase; RANK Ligand; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.
Topics: Angiogenesis Inhibitors; Anoikis; Carcinoma, Squamous Cell; Cells, Cultured; Head and Neck Neoplasms; Humans; Molybdenum; Neoplasm Invasiveness; Neoplasm Metastasis | 2010 |
The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Biopsy, Needle; Carcinoma, Squamous Cell; Cell Movement; Cytokines; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, SCID; Molybdenum; Neovascularization, Pathologic; Probability; Rats; Rats, Sprague-Dawley; Risk Assessment; Sensitivity and Specificity; Species Specificity; Tumor Burden; Tumor Cells, Cultured | 2005 |
Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Ceruloplasmin; Chelating Agents; Combined Modality Therapy; Head and Neck Neoplasms; Mice; Mice, Inbred C3H; Molybdenum; Random Allocation | 2006 |
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer.
Topics: Adenosine Triphosphatases; Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Movement; Ceruloplasmin; Disease Models, Animal; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mice, Nude; Molybdenum; Necrosis; Neovascularization, Pathologic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Awards and Prizes; Carcinoma, Squamous Cell; Ceruloplasmin; Chelating Agents; Copper; Head and Neck Neoplasms; Male; Mice; Mice, Inbred C3H; Molybdenum; Neoplasm Transplantation | 2001 |